PFBT
SLS icon

Parkside Financial Bank & Trust’s SELLAS Life Sciences SLS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9 Hold
2
– – ﹤0.01% 2682
2025
Q4 		$8 Hold
2
– – ﹤0.01% 2675
2025
Q3 		$4 Hold
2
– – ﹤0.01% 2705
2025
Q2 		$5 Hold
2
– – ﹤0.01% 2726
2025
Q1 		$3 Hold
2
– – ﹤0.01% 2733
2024
Q4 		$3 Hold
2
– – ﹤0.01% 2139
2024
Q3 		$3 Hold
2
– – ﹤0.01% 2095
2024
Q2 		$3 Hold
2
– – ﹤0.01% 2041
2024
Q1 		$3 Hold
2
– – ﹤0.01% 2029
2023
Q4 		$3 Hold
2
– – ﹤0.01% 2044
2023
Q3 		$4 Hold
2
– – ﹤0.01% 2048
2023
Q2 		$4 Hold
2
– – ﹤0.01% 2014
2023
Q1 		$3 Hold
2
– – ﹤0.01% 2007
2022
Q4 		$5 Hold
2
– – ﹤0.01% 2012
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1932
2022
Q2 		$0 Buy
+2
New +$6 ﹤0.01% 1937

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Parkside Financial Bank & Trust's SLS Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its SELLAS Life Sciences (SLS) position steady in Q1 2026 at 2 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #2682.

Parkside Financial Bank & Trust first reported a position in SLS in Q2 2022 and has held it in 16 quarters since. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Parkside Financial Bank & Trust held 2 shares of SELLAS Life Sciences worth $9 as of Q1 2026.
  • Parkside Financial Bank & Trust left its SELLAS Life Sciences share count unchanged in Q1 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2682 holding.
  • Parkside Financial Bank & Trust first reported a position in SELLAS Life Sciences in Q2 2022 and has held it in 16 quarters since.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.